A RECORD-BREAKING NUMBER OF CONSUMERS
PARTICIPATED, WITH BOGO GIFT CARDS SELLING OUT IN JUST A FEW
HOURS11
IRVINE,
Calif., Nov. 17, 2022 /PRNewswire/ -- Yesterday,
Allergan Aesthetics, an AbbVie company (NYSE: ABBV),
celebrated the fourth annual – and most successful –
BOTOX® Cosmetic Day yet.
Once again, the day was met with record-breaking numbers, with
BOTOX® Cosmetic seeing the largest treatment day on the
books in the brand's 20-year history.11
- The day saw the highest single day of Allē registrations in the
history of the company.11
- Within the first hour, the BOTOX® Cosmetic Day site
had more than 285,000 visitors.11
- The site also saw a 130% increase in searches for local
healthcare providers online to explore
BOTOX® Cosmetic treatment options in their area,
compared to last year.11
- The highest number of BOGO gift cards were sold in
BOTOX® Cosmetic Day history exceeding 2021 by
20%.11
- The brand saw over 25,000 social media posts and mentions
leading up to BOTOX® Cosmetic Day.11
"Our record-breaking traffic this BOTOX® Cosmetic Day
demonstrates how excited people are about BOTOX®
Cosmetic. I think that is because of the natural looking results
BOTOX® Cosmetic offers at the hands of our esteemed
providers12,*,**," said Jasson
Gilmore, Senior Vice President, Allergan Data Labs. "The
proof of this successful day is in the numbers and we hope to make
this holiday an even better experience for our customers and
providers next year."
BOTOX® Cosmetic is the first and only product of
its kind FDA approved to temporarily improve the look of moderate
to severe frown lines, crow's feet lines and forehead lines in
adults, with full results in 30 days.2-6 No other
product on the market has received FDA approval for use in crow's
feet lines or forehead lines.2-6 Based on results from
an online market research survey, 94% of neurotoxin patients deemed
FDA approval as very (73%) to somewhat (21%) important to
them.7† BOTOX® Cosmetic
offers more than 20 years of research and real-world
experience.8 It is the most widely researched and
studied treatment of its kind and is approved for use in 98
countries.9 The safety and efficacy of BOTOX®
Cosmetic have been described in more than 604 peer-reviewed
articles in scientific and medical journals.9
For those unable to secure a gift card, the two-week-long offer
of double points on BOTOX® Cosmetic treatments powered
by Allē is still available until November 30, 2022. To
stay current on the latest information, consumers can join Allē, a
resource hub for additional information, exclusive offers,
personalized content and more. Check
out https://alle.com/botoxcosmeticday for the terms and
conditions of this offer.
*Patients combined from two studies treated for their
forehead and frown lines reported being "Mostly or Very Satisfied"
with the natural looking result of treatment.
**In two clinical trials, 90% and 82% of patients
reported they were "Mostly or Very Satisfied" (top 2 out of 5
responses) with their treatment results at Day 60.
†Results from an online market research
survey of patients who received a neurotoxin at least once within
the last 2 years.
BOTOX® Cosmetic Important Safety
Information & Approved Uses
BOTOX® Cosmetic may cause serious side
effects that can be life threatening. Get medical help right away
if you have any of these problems any time (hours to weeks) after
injection of BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to weakening
of associated muscles, can be severe and result in loss of life.
You are at the highest risk if these problems are pre-existing
before injection. Swallowing problems may last for several
months.
- Spread of toxin effects. The effect of botulinum toxin may
affect areas away from the injection site and cause serious
symptoms including: loss of strength and all-over muscle weakness,
double vision, blurred vision and drooping eyelids, hoarseness or
change or loss of voice, trouble saying words clearly, loss of
bladder control, trouble breathing, and trouble swallowing.
BOTOX® Cosmetic dosing units are not
the same as, or comparable to, any other botulinum toxin
product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or
general muscle weakness, vision problems, or dizziness within hours
to weeks of taking BOTOX® Cosmetic. If this
happens, do not drive a car, operate machinery, or do other
dangerous activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if
you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for
ingredients); had an allergic reaction to any other botulinum toxin
product such as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), or
Xeomin® (incobotulinumtoxinA); have a skin
infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou Gehrig's disease,
myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects including difficulty
swallowing and difficulty breathing from typical doses of
BOTOX® Cosmetic.
Tell your doctor about all your medical conditions,
including: plans to have surgery; had surgery on your
face; have trouble raising your eyebrows; drooping eyelids; any
other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can
harm your unborn baby); are breast-feeding or plan to (it is not
known if BOTOX® Cosmetic passes into breast
milk).
Tell your doctor about all the medicines you take, including
prescription and over-the-counter medicines, vitamins, and herbal
supplements. Using BOTOX® Cosmetic with
certain other medicines may cause serious side effects. Do not
start any new medicines until you have told your doctor that you
have received BOTOX® Cosmetic in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic
include: dry mouth; discomfort or pain at the injection
site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and
eyebrows, swelling of your eyelids and dry eyes.
APPROVED USES
BOTOX® Cosmetic is a
prescription medicine that is injected into muscles and used to
temporarily improve the look of moderate to severe forehead lines,
crow's feet lines, and frown lines between the eyebrows in
adults.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full Product
Information including Boxed Warning and Medication
Guide.
About Allergan Aesthetics
Allergan Aesthetics, an
AbbVie company, develops, manufactures, and markets a portfolio of
leading aesthetics brands and products. Their aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Their goal is to consistently provide customers worldwide
with innovation, education, exceptional service, and a commitment
to excellence, all with a personal touch.
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines that solve serious health issues today
and address the medical challenges of tomorrow. We strive to have a
remarkable impact on people's lives across several key therapeutic
areas: immunology, oncology, neuroscience, eye care, virology,
women's health and gastroenterology, in addition to products and
services across its Allergan Aesthetics portfolio. For more
information about AbbVie, please visit us
at www.abbvie.com. Follow @abbvie on Twitter, Facebook,
Instagram, YouTube and LinkedIn.
References
- Data on File. AbbVie. Neurotoxin Monthly Tracker Report,
August 2022.
- BOTOX® Cosmetic Prescribing Information,
July 2020.
- Dysport® Prescribing Information, 2020.
- Xeomin® Prescribing Information, 2020.
- Jeuveau® Prescribing Information, 2020.
- Daxxify™ Prescribing Information, 2022.
- Data on File. AbbVie. Facial Injectables Neurotoxins Consumer
A&U Tracker, 2014.
- Data on File. AbbVie. FDA Product Approval Information,
2019.
- Data on file, Allergan, 2018; Country Approvals Worldwide
Marketing Authorization.
- Data on File. AbbVie. Botulinum Toxin Peer-Reviewed
Publications, 2021.
- Data on File. Allergan. November
2022.
- Data on File. AbbVie. Ogilvie, "Pooled Subject-Reported
Outcomes From 2Phase 3 Studies of OnabotulinumtoxinA for
Simultaneous Treatment of Forehead and Glabellar Lines," 2020.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fourth-annual-botox-cosmetic-onabotulinumtoxina-day-most-successful-one-yet-301681101.html
SOURCE AbbVie